Literature DB >> 9156378

The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s.

D Armstrong, H Neu, L R Peterson, A Tomasz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 9156378     DOI： 10.1089/mdr.1995.1.1

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN： 1076-6294            Impact factor:   3.431


× No keyword cloud information.
  6 in total

1.  Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.

Authors:  D M Hacek; D C Dressel; L R Peterson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Laboratory perspectives: Population biology and the 'new' enterococcus.

Authors:  W M Johnson; M B Coulthart
Journal:  Can J Infect Dis       Date:  1996-03

3.  Antimicrobial activities of squalamine mimics.

Authors:  K Kikuchi; E M Bernard; A Sadownik; S L Regen; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Synthesis, characterization and antimicrobial properties of two derivatives of pyrrolidine-2,5-dione fused at positions-3,4 to a dibenzobarrelene backbone.

Authors:  Emmanuel Sopbué Fondjo; Abdou Salamou Njoya; Jean-de-Dieu Tamokou; Giscard Doungmo; Bruno Ndjakou Lenta; Peter F W Simon; Apollinaire Tsopmo; Jules-Roger Kuiate
Journal:  BMC Chem       Date:  2022-03-03

5.  Synergistic interactions of methanolic extract of Acacia mearnsii De Wild. with antibiotics against bacteria of clinical relevance.

Authors:  Olufunmiso O Olajuyigbe; Anthony J Afolayan
Journal:  Int J Mol Sci       Date:  2012-07-17       Impact factor: 6.208

6.  Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?

Authors:  Chanaz Salmi; Celine Loncle; Nicolas Vidal; Yves Letourneux; Jacques Fantini; Marc Maresca; Nadira Taïeb; Jean-Marie Pagès; Jean Michel Brunel
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.